Login Register
English
0

Cart

$ 0
OR
Catalog no Product name Protocol name IF Magazine title
A21020 HRP, Goat Anti-Rabbit IgG RASSF1A independence and early galectin‐1 upregulation in PIK3CA‐induced hepatocarcinogenesis: new therapeutic venues(A21020-4.5) 4.5 Molecular Cancer 
PRP100190 Human TGF-β1 protein Rapid, Large‐scale, and Precise Cell Assembly for Tumor Model Fabrication via Template‐modulated Flow‐driven Strategy(PRP100190-6.2) 6.2 Biomedicine & Pharmacotherapy
KTA1001 Live and Dead Cell Double Staining Kit Rational Design of Ultrabright NIR-II Nanofluorophores with Enhanced Photothermal Conversion Efficiency for Targeted Chemodynamic-Hypothermal Photothermal Therapy of Hepatocellular Carcinoma.(KTA1001-10.2) 10.2 Cell Death & Disease
A21010 HRP, Goat Anti-Mouse IgG Rational design of indoleamine 2, 3-dioxygenase 1 (IDO1) inhibitors featuring 1, 2, 3-triazole derivatives with enhanced anti-inflammatory and analgesic …(A21010-4.8) 4.8 J Thromb Thrombolysis
KTL0521 LinKine™ AbFluor™ 488 Labeling Kit (Optimized for samples with molecular weight of 6 KD to 20 KD) Rational engineering of an antifreeze-based biomaterial with dual-enhanced ice-binding and delivery for high-efficiency cryopreservation(KTL0521-13) 13 Respiratory Research
KTD104 RBM5 recruiting MGC32805 in a sandwich mode and inducing ΔFAS neoantigen and triggering FAS properties switch: implication in colorectal cancer.(KTD104-7.3) 7.3 Oncogene 
KTA1001 Live and Dead Cell Double Staining Kit Rationally Engineered Adenosine A2A Decoy Receptor for Reversing Immunosuppression of Breast Cancer(KTA1001-12.1) 12.1 Food Analytical Methods (2017): 1-7
BMP2020 WB (IP) Lysis Buffer Rbms1 promotes pulmonary fibrosis by stabilising Sumo2 mRNA to facilitate Smad4-SUMOylation and fibroblast activation.(BMP2020-21) 21 European Respiratory Journal 
A23210 DyLight 488, Goat Anti-Mouse IgG Received 10 July 2024; received in revised form 15 September 2024; accepted 26 November 2024* Corresponding authors. E-mail addresses: zhiping0414 …(A23210-) Sensors and Actuators B: Chemical
BMU102 Receptor of advanced glycation end products deficiency attenuates cisplatin-induced acute nephrotoxicity by inhibiting apoptosis, inflammation and restoring …(BMU102-4.8) 4.8 J Affect Disord